A new drug being tested for colorectal cancer has come back with 100% success rate in recent clinical trials.
Researchers were taken aback when Dostarlimab, a drug with laboratory-produced molecules that act as a replacement for antibodies, left all 18 participants in remission one year later. According to the New York Times, doctors performed several tests and scans and could find no indication of cancer in their bodies.
It was ‘the first time this has happened in the history of cancer’ said Dr Luis A. Diaz Jr. of New York's Memorial Sloan Kettering Cancer Center. He and his team released their findings in the New England Journal of Medicine. It was also noted that none of the patients suffered any significant issues following the treatment.
Each year, over 2700 people in Ireland get diagnosed with colorectal or bowel cancer. Dostarlimab is the latest of many cancer drug treatments. Research such as this and others mean we are closer than ever to a cure.
